Global Healthcare Company To Pay $6.3 Million To Resolve False Claims Act Allegations
NEWARK, N.J. – A global healthcare company has agreed to pay $6.3 million to resolve allegations that it violated the False Claims Act by selling items to the United States that were manufactured in non-designated countries in violation of the Trade Agreements Act of 1979, U.S. Attorney Philip R. Sellinger announced today.
Action Details
- Date:August 31, 2022
- Agency:U.S. Attorney’s Office, District of New Jersey
-
Enforcement Types:
- Criminal and Civil Actions